This maintenance phase is where your muscle mass becomes your greatest asset
When researchers talk about tirzepatide going bad, they are describing changes at this molecular level that reduce or eliminate the peptide ability to bind its target receptors and produce therapeutic effects
2025;6:1001378 DOI: Received: October 01, 2025 Accepted: December 04, 2025 Published: December 17, 2025 Academic Editor: Alessandro Granito, University of Bologna, Italy The management of metabolic dysfunction-associated steatohepatitis (MASH) has evolved significantly, transitioning from a lack of therapeutic options to resmetiroma and semaglutide being licensed for use in MASH
Also, when semaglutide is released into the bloodstream, it slows the rate at which food leaves the stomach by slowing down the absorption of nutrients from the digestive tract into the bloodstream
Owing to these actions, the principal sites of POMC expression and its processing into biologically active -MSH lie within the central nervous system (hypothalamus and pituitary gland) and in the skin, but there is some evidence demonstrating that -MSH is also produced in other peripheral tissues (Smith and Funder, 1988)